• Non ci sono risultati.

FORUM PROGRAM

N/A
N/A
Protected

Academic year: 2021

Condividi "FORUM PROGRAM"

Copied!
6
0
0

Testo completo

(1)

DAY 1 _ TUESDAY MAY 16

TH

2017

8.30 - 9.15 Registration

9.30 - 10.30 OPENING ADDRESSES

CHAIR -

Gabriella Pravettoni Forum General Secretary, Università degli Studi di Milano (UNIMI) and Euroean Institute of Oncology (IEO), Italy

Gianluca Vago, Rector of the Università degli Studi di Milano Anna Scavuzzo, Deputy Mayor of Milan

Giulio Gallera, Councilor Welfare Lombardy Region Roberto Carlo Rossi, President OMCeO, Italy

David Byrne, Chair of the European Alliance for Personalised Medicine (EAPM), Belgium

Fortunato Ciardiello, President of the European Society for Medical Oncology (ESMO), Italy

10.30 - 11.30 PLENARY SESSION I

REACHING CONSENSUS TO BUILD A EUROPE OF EQUITY IN CANCER CARE

CHAIR - Filippo de Braud Istituto Nazionale dei Tumori, Italy

Peter Selby, European Cancer Concord (ECC) and University of Leeds, UK

Francesco De Lorenzo, President of the European Cancer Patient Coalition (ECPC), Italy

Tit Albreht, CANCON, Slovenia

Ciarán Nicholl, Research Centre Ispra, European Commision, Belgium

Mark Lawler, European Cancer Concord (ECC) and Queen's University Belfast, Northern Ireland

11.45 – 13.30 PLENARY SESSION II

ACCESS TO INNOVATION VS SUSTAINABILITY: INVOLVING PATIENTS IN SETTING THE PRIORITIES

CHAIR – Massimo Di Maio Associazione Italiana di

Oncologia Medica (AIOM), Italy

Bengt Jönsson, Stockholm School of Economics, Sweden Mario Melazzini, Agenzia Italiana del Farmaco (AIFA), Italy Massimo Scaccabarozzi, Farmindustria, Italy

Alberto Sobrero, European Society for Medical Oncology (ESMO), Italy

Peter Naredi, European Cancer Organization (ECCO), Belgium Rosanna D’Antona, Europa Donna Italia, Italy

13.30 – 14.30 Speakers Lunch

FORUM PROGRAM

(2)

14.30 - 15.30

PLENARY SESSION III

EUROPEAN REFERENCE NETWORKS: MAKING CROSS-BORDER CANCER HEALTHCARE A REALITY

CHAIR - Gordon McVie King’s College London, UK

Paolo Casali, Joint Action on Rare Cancers (JARC), Italy Anna Carta, European Reference Networks (ERNs), Belgium Denis Lacombe, European Organization for Research and Treatment of Cancer (EORTC), Belgium

Jana Pelouchova, European Cancer Patient Coalition (ECPC), Diagnoza Leukemie, Czech Republic

Ian Banks, European CanCer Organization (ECCO), UK

15.45 – 16.45 THEMATIC SESSION I

SHARED CLINICAL DECISION-MAKING AND DOCTOR RESPONSIBILITY

CHAIR - Ketti Mazzocco Università degli Studi di Milano, Italy

Paolo G. Casali, European Society for Medical Oncology (ESMO), EU Policy Committee, Italy

Francesco Pignatti, European Medicines Agency, UK Conny Berlin, Novartis, Switzerland

Akulin Igor Mikhaylovich, St. Petersburg State University Department of Public Health Organization, Russia

Riccardo Valdagni, Istituto Nazionale dei Tumori, Italy

15.45 – 16.45 THEMATIC SESSION II

SURVIVORSHIP AND SUPPORTIVE CARE FOR CANCER PATIENTS QUALITY OF LIFE

CHAIR - Antonella Piga Università degli Studi di Milano, Italy

Claudia Ferrari, French National Cancer Institute (INCa), France Françoise Meunier, European Organization for Research and Treatment of Cancer (EORTC), Belgium

Carla Ripamonti, Istituto Nazionale dei Tumori, Italy Luzia Travado, The International Psycho-Oncology Society (IPOS), Champalimaud Clinical Center, Portugal

Kathi Apostolidis, Hellenic Cancer Federation (ELL.O.K) and European Cancer Patient Coalition (ECPC), Greece

15.45 – 16.45 THEMATIC SESSION III

MANAGEMENT OF BLOOD COMPLICATIONS IN HEMATOLOGY – ONCOLOGY:

ANEMIA, BLEEDING AND THROMBOSIS

CHAIR - Paolo Corradini Università degli Studi di Milano, Italy

Anna Falanga, Head of Immuno-Hematology and Thrombosis Center, Bergamo Hospital, GIMEMA Group on Hemostasis and Thrombosis, Italy

Augusto B. Federici, L. Sacco Hospital, GIMEMA Group on Hemostasis and Thrombosis, Italy

Frank Leebeek, Erasmus Medical Center, The Netherlands Silvia Riva, Università degli Studi di Milano, Italy

Felice Bombaci, Gruppo AIL Pazienti Malattie Ematologiche, Italy

(3)

16.45 - 17.55

PLENARY SESSION IV

ETHICS COMMITTEES FOR CANCER PATIENT’S EMPOWERMENT.

PAST, PRESENT AND FUTURE DIRECTIONS

CHAIR - Livia Pomodoro Milan Centre for Food Law and Policy, Italy

CHAIR - Pierpaolo Di Fiore Istituto FIRC di Oncologia Molecolare (IFOM), Italy

Peter O’Donnell, Journalist, Belgium

Virginia Sanchini, Istituto FIRC di Oncologia Molecolare (IFOM), , Università degli Studi di Milano, Italy

Mark Aulisio, Center for Biomedical Ethics at Metro Health, USA Bert Molewijk, VU Medical Center in Amsterdam, The

Netherlands

Loredana Bergamini, Janssen Italia, Italy

18.00 – 19.00 ROUND TABLE

BIG KILLERS AND RARE CANCERS TODAY

CHAIR - Giuseppe Curigliano European Institute of Oncology (IEO), Italy

Fabrice André, Institut Gustave Roussy, France Marina Garassino, Istituto Nazionale dei Tumori, Italy Lisa Licitra, Istituto Nazionale dei Tumori, Italy

Domenica Lo Russo, Istituto Nazionale dei Tumori, Italy Virgilio Sacchini, European Institute of Oncology (IEO), Italy Salvatore Siena,Università degli Studi di Milano e Niguarda Cancer Center, Italy

18.00 – 19.00 SATELLITE SYMPOSIUM

EMPOWER PATIENTS AS POLICY INFLUENCERS

CHAIR – Donatella Barus Editor in Chief

www.fondazioneveronesi.it

, Italy

PATIENTS’ PANEL:

Ian Banks, European Cancer Organization (ECCO), UK

Ornella Campanella, Associazione aBRCAdaBRA ONLUS, Italy Francesco De Lorenzo, European Cancer Patient Coalition (ECPC), Italy

Antonio Gaudioso, Cittadinanzattiva, Italy Nicoletta Luppi, MSD Italia, Italy

Susanna Leto, Salute Donna Onlus, Italy

Jana Pelouchova, European Cancer Patient Coalition (ECPC), Diagnoza Leukemie, Czech Republic

19.00 – 19.30 CONCERT IN AULA MAGNA:

Quartetto Guadagnini in memory of Laura Dubini: QUARTETTI PER LAURA

(4)

DAY 2 _ WEDNESDAY MAY 17

TH

2017

8.30 - 9.15 Registration

9.30 - 10.00 OPENING SESSION

UNIVERSITY ONCOLOGY DEPARTMENT (DIPO), A NEW APPROACH TO CANCER CARE

Gianluca Vago, Rector of the Università degli Studi di Milano, Italy

Paolo Corradini, Director of the Dipartimento di Oncologia ed Emato-Oncologia (DIPO), Università degli Studi di Milano, Italy

10.15 - 11.15

PLENARY SESSION I

EU ACTION PLANS, WHAT’S NEXT FOR PATIENTS EMPOWERMENT?

CHAIR - Gabriella Pravettoni Università degli Studi di Milano and European Institute of Oncology (IEO), Italy

Alberto Costa, European School of Oncology (ESO), Italy

Karen Benn, Europa Donna -The European Breast Cancer Coalition, Italy

Paola Kruger,Patient Expert, EUPATI Fellow

.

Louis Denis, Europa Uomo, Belgium Robert Mansel, EUSOMA, UK

11.30 –

13.00

PLENARY SESSION II

TRANSLATIONAL RESEARCH: FROM BENCH TO BEDSIDE

CHAIR – Fedro Peccatori, European School of Oncology (ESO), Italy

Fatima Cardoso, European Society for Medical Oncology (ESMO), Portugal

Barbara Fossa-Jereczek, European Institute of Oncology (IEO), Italy Giancarlo Pruneri, European Institute of Oncology (IEO), Italy Peter Selby, European Cancer Concord (ECC) and University of Leeds, UK

13.00 –

14.15 Speakers Lunch

(5)

14.30 – 14.45 OPENING PLENARY SPEECH

Beatrice Lorenzin, Italian Minister of Health (invited)

14.45 – 15.45 PLENARY SESSION

HEALTH AND THE SMART PROGRAMS FOR REMOTE PATIENT MONITORING

CHAIR - Gordon McVie, King’s College London, UK

Stephan Kiefer,Fraunhofer Institute for Biomedical Engineering, Germany

Mariano Alcañiz Raya, Laboratorio de Neurotecnologias Inmersivas (LENI), Universidad Politécnica de Valencia, Spain Sergio Scaccabarozzi, Roche, Italy

Yuval Shaked, Technion - Israel Institute of Technology, Israel

16.00 – 17.30 THEMATIC SESSION I

BACK TO WORK: EMPLOYMENT PROTECTIONS FOR PATIENTS AND THEIR FAMILIES

CHAIR - Alessandra Gorini Università degli Studi di Milano, Italy

Silvia Fernández Martínez, Università di Bergamo, Italy

Kate Field, Institution of Occupational Safety and Health (IOSH), UK Diana Kloss, Manchester University, UK Council for Work and Health, UK

Elisabetta Iannelli, Osservatorio Malati di Cancro, Federazione Italiana delle Associazioni di Volontariato in Oncologia ONLUS (FAVO), Italy

Giulia Di Donato, Osservatorio Nazionale sulla salute della Donna (ONDA)

16.00 – 17.30

THEMATIC SESSION II

EMPOWERING PATIENTS AND STRENGHTENING SELF MANAGEMENT IN CANCER DISEASE

CHAIR - Stephan Kiefer,

Fraunhofer Institute

for Biomedical Engineering, Germany

Xu Zhang, University of Bedfordshire, UK Stephen Wilson, University of Bedfordshire, UK

Haridimos Kondylakis, Foundation of Research & Technology- Hellas (FORTH), Greece

Lefteris Koumakis, Foundation of Research & Technology-Hellas (FORTH), Greece

16.00 – 17.30 THEMATIC SESSION III

CARE NURSING IMPACT ON PATIENT EMPOWERMENT

CHAIR – Denis Horgan,

European Alliance for PersonalisedMedicine (EAPM), Belgium

Alessio Piredda, Associazione Italiana Infermieri di Area Oncologica (AIIAO), Italy

Alessandra Milani, European Institute of Oncology (IEO), Italy Orejeta Diamanti, Istituto Oncologico Veneto, Italy

Giusta Greco, USL Modena, Italy

(6)

16.15 – 18.15 SATELLITE SYMPOSIUM

FROM GENOMIC MEDICINE TO PERSONALIZED MEDICINE

CHAIR –Ruggero De Maria Alliance against Cancer (ACC), Italy

Pier Giuseppe Pelicci, European Institute of Oncology (IEO), Università degli Studi di Milano, Italy

Fortunato Ciardiello, European Society for Medical Oncology (ESMO) and Università degli Studi di Napoli Federico II, Italy Tariq Mughal, Tufts University Medical Center, USA

Yuval Shaked, Technion - Israel Institute of Technology, Israel Gianluca Fincato, Novartis, Italy

17.15 – 18.15 SATELLITE SYMPOSIUM organized by Interdepartmental Center for Palliative Care THE INTEGRATION OF PALLIATIVE CARE AND ONCOLOGY

CHAIR - Francesco Onida Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Italy

Camilla Zimmerman, University of Toronto, Canada Momcilo Jankovic, Fondazione Floriani, Italy

Augusto Caraceni, European Association for Palliative Care

Research Network (EAPC), Istituto Nazionale dei Tumori, Italy Furio Zucco, Università degli Studi di Milano, Italy, Associazione Volontariato Presenza Amica Onlus, Associazione Science and Therapy

18.15 – 19.00 CLOSING REMARKS

Paolo Corradini, Direttore DIPO, Università degli Studi di Milano, Italy

Gabriella Pravettoni, Forum General Secretary, Università degli Studi di Milano, European Institute of Oncology (IEO), Italy

Riferimenti

Documenti correlati

Dipartimento di Scienze della Vita (D.S.V.), Università degli Studi di Trieste

Ra diologo, Chirurgia pla stica ricostruttiva , Ana tomia pa tologica , Oncologia Me dica , Ra diote ra pia , Me dicina Nucle a re , Ria bilita zione , Ge ne tica clinica

a) In caso di congedi e assenze a qualunque titolo, ad eccezione delle diverse tipologie di aspettativa senza assegni, il periodo soggetto a valutazione in

Titolo di studio: Laurea in Storia e Filosofia (110 con lode) nell’Università Cattolica di Milano Giornalista professionista dal 1964. Esperienze professionali: Il Giorno,

Oncologia Medica 3 - Tumori della testa e del collo Fondazione IRCCS Istituto Nazionale Tumori-INT Università degli Studi Milano. Domenica

Giuseppe Di Lucca – IRCCS Ospedale San Raffaele (Milano, Italy) Massimo Di Nicola – IRCCS Istituto Nazionale dei Tumori (Milano, Italy) Claudio Doglioni – Università Vita-Salute

MARIO PAOLO COLOMBO (Istituto Nazionale Tumori, Milano, Italy) FILIPPO DE BRAUD (Istituto Nazionale Tumori, Milano, Italy) MICHELE DEL VECCHIO (Istituto Nazionale Tumori, Milano,

Oncologia Medica 3 - Tumori della testa e del collo Fondazione IRCCS Istituto Nazionale Tumori-INT Università degli Studi Milano. Domenica